GLP-1 Pharmacology Glucagon-like peptide 1 agonists simulate the action of incretin, which is a hormone produced by the small intestines, that bind to the GLP-1 receptor
We know that endometriosis is driven by multiple cellular factors, including hormone dysfunction, inflammation, oxidative stress, oncogenic cellular proliferation, invasion into surrounding tissues, and neuromodulation
Stubblefield MD, McNeely ML, Alfano CM, Mayer DK
Researchers study this combination to examine dual-pathway GH stimulation, pulsatile versus sustained release patterns, and interactions between the hypothalamic GHRH pathway and the gastric ghrelin signaling system
Faster Action: Results can appear within 46 weeks with regular use